Researchers at WashU Medicine have developed a nasal vaccine against the highly pathogenic H5N1 avian influenza virus, or bird flu, which has jumped from wild birds to livestock to humans.

Media reports say that antibodies against H5N1 avian flu have been detected in five cows in the Netherlands province of Northeast Friesland, although officials have yet to confirm the finding.

Explore France's groundbreaking HPAI vaccination strategy, cutting outbreak risks and transforming poultry sector resilience.

Sanofi's sales grew 9.9% YoY – driven by a diverse range of portfolio classics and new launches across immunology, oncology and rare disease.

The Harbor Small Cap Growth Fund delivered a 3.09% return in Q4 2025, outperforming its Russell 2000 Growth Index benchmark. Click here to read more.

VANCOUVER, BC, CANADA, January 15, 2026 / EINPresswire.com / — Eyam Health and iiDiagnostics (iiDX), a company formed by the ...

The recently released report from the Lancet Commission calls for ‘a citizen-centred and technology driven system’ for Universal Health Care (UHC) in India. Lack of UHC is a worrying problem for a ...

Earlier on January 10, Pfizer Inc. (NYSE: PFE) announced positive results from Cohort 3 of its pivotal BREAKWATER trial. This specific randomized cohort evaluated the BRAFTOVI regimen in combination ...

Gideon Rachman The closure of USAID by the Trump administration was met with real horror by many of those who are trying to ...

The University of Pittsburgh secured $1.5 million through a federal tax credit program for its BioForge project in Hazelwood ...

According to an article on Earth.com, the risk of H5N1 to the general public remains low. In 2024, the United States reported 66 confirmed and seven probable human cases, with most producing mild ...

The United States formally withdrew from the World Health Organization after President Donald Trump cited the agency’s handling of COVID-19, alleged failures to reform and what he has described as ...